Figure 2From: Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapyOverall survival (A, P = 0.002) and progression free survival (B, P = 0.001) according to absolute lymphocyte count (ALC) in PTCL, NOS patients with high-intermediate/high risk IPI.Back to article page